Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Rubinstein Julie sold 35,643 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Oct 9 to Oct 13, 2026 · Filed Oct 13, 2026

From Oct 9 to Oct 13, 2026, Rubinstein Julie (President and COO) sold 35,643 Adaptive Biotechnologies Corporation shares at an average US$25.81 for US$920K under a trading plan, leaving 377,802 shares. Filed Oct 13, 2026 (Form 4).

Sold
35,643 shares
Price
US$25.81 average (US$25.35 to US$26.41)
Value
US$920K
Holding after
377,802 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President and COO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 9, 2026Common StockOption exercise11,881US$12.14389,683Direct
Oct 9, 2026Common StockSale11,881US$26.41377,802Direct
Oct 12, 2026Common StockOption exercise11,881US$12.14389,683Direct
Oct 12, 2026Common StockSale9,181US$25.35380,502Direct
Oct 12, 2026Common StockSale2,700US$26.07377,802Direct
Oct 13, 2026Common StockOption exercise11,881US$12.14389,683Direct
Oct 13, 2026Common StockSale11,881US$25.50377,802Direct

Source

View original at SEC

Related